Glucotrack Inc (GCTK)

$0.41 -0.08 (-16.87%)
Market Cap 3.08M
Revenue (ttm) 0.00
Net Income (ttm) -19.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -4.19
Volume 1,869,900
Avg Vol 4,071,504
Day's Range N/A - N/A
Shares Out 6.26M
Stochastic %K 28%
Beta 0.77
Analysts Strong Buy
Price Target N/A

Company Profile

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 200...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 842 7715
Address:
301 Route 17 North, Suite 800, Rutherford, United States
Ricksal
Ricksal Jul. 21 at 4:47 AM
$GCTK as long as it’s not delisted you will be fine. These penny stocks make monumental moves when they do move.
0 · Reply
Homer_Simpson82
Homer_Simpson82 Jul. 21 at 2:56 AM
$GCTK no
0 · Reply
Zackpedia
Zackpedia Jul. 20 at 7:34 PM
$GCTK Down to .39, you could’ve sold and bought back now if you wanted.
0 · Reply
OG80
OG80 Jul. 20 at 7:06 PM
$GCTK delist. pay me.
0 · Reply
CallMeMyBeer
CallMeMyBeer Jul. 20 at 5:46 PM
$GCTK
0 · Reply
OG80
OG80 Jul. 20 at 5:20 PM
$GCTK not selling 🖕
0 · Reply
dunkcanfish
dunkcanfish Jul. 20 at 5:05 PM
$GCTK garbage
0 · Reply
Stockswingalert
Stockswingalert Jul. 20 at 1:16 PM
$KNDI .70 here 👇👇👇👇 Literally free money if you have noti’s on using the high frequency trader cc $GCTK last week 104% mover 💰💰💰💰 @Stocktwits for the 🎯🎯🎯👇👇👇📈📈📈
0 · Reply
sloeb
sloeb Jul. 20 at 12:54 PM
$GCTK bullish
0 · Reply
Phazzatrades
Phazzatrades Jul. 20 at 10:48 AM
$GCTK
0 · Reply
Latest News on GCTK
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing

Jul 17, 2026, 1:20 PM EDT - 3 days ago

E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing

Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives

Jul 17, 2026, 8:05 AM EDT - 3 days ago

Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives

GlucoTrack Proxy statement: Proxy filing

Jul 17, 2026, 8:00 AM EDT - 3 days ago

GlucoTrack Proxy statement: Proxy filing

UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

Jul 16, 2026, 4:57 PM EDT - 4 days ago

UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

Jul 14, 2026, 5:40 PM EDT - 6 days ago

Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

GlucoTrack announces USPTO notice of allowance for patent application

2026-07-08T12:16:14.000Z - 12 days ago

GlucoTrack announces USPTO notice of allowance for patent application

Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform

Jul 8, 2026, 8:00 AM EDT - 12 days ago

Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform

GlucoTrack Proxy statement: Proxy filing

Jun 17, 2026, 8:00 AM EDT - 4 weeks ago

GlucoTrack Proxy statement: Proxy filing

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions

May 26, 2026, 8:00 AM EDT - 7 weeks ago

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions

Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

May 14, 2026, 5:27 PM EDT - 2 months ago

Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

GlucoTrack Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 2 months ago

GlucoTrack Quarterly report: Q1 2026

GlucoTrack Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 2 months ago

GlucoTrack Earnings release: Q1 2026

GlucoTrack submits IDE application to initiate study for CBGM technology

2026-05-07T17:06:12.000Z - 2 months ago

GlucoTrack submits IDE application to initiate study for CBGM technology

Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology

May 7, 2026, 1:00 PM EDT - 2 months ago

Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology

GlucoTrack Slides: Investor presentation

May 5, 2026, 7:00 AM EDT - 2 months ago

GlucoTrack Slides: Investor presentation

Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology

Apr 30, 2026, 9:00 AM EDT - 2 months ago

Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology

GlucoTrack announces publication of peer-reviewed article on glucose sensors

2026-04-21T13:32:23.000Z - 3 months ago

GlucoTrack announces publication of peer-reviewed article on glucose sensors

Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology

Apr 21, 2026, 8:00 AM EDT - 3 months ago

Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology

Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Mar 30, 2026, 4:50 PM EDT - 4 months ago

Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

GlucoTrack Earnings release: Q4 2025

Mar 30, 2026, 7:00 AM EDT - 4 months ago

GlucoTrack Earnings release: Q4 2025

GlucoTrack Annual report: Q4 2025

Mar 30, 2026, 7:00 AM EDT - 4 months ago

GlucoTrack Annual report: Q4 2025

Why is Glucotrack Stock (GCTK) Up Nearly 30% Today?

2026-03-27T13:29:54.000Z - 4 months ago

Why is Glucotrack Stock (GCTK) Up Nearly 30% Today?

GlucoTrack to file IDE to FDA for continuous blood glucose monitoring technology

2026-03-27T12:34:29.000Z - 4 months ago

GlucoTrack to file IDE to FDA for continuous blood glucose monitoring technology

Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones

Mar 27, 2026, 8:01 AM EDT - 4 months ago

Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones

GlucoTrack Transcript: EGM 2026

Mar 12, 2026, 11:00 AM EDT - 4 months ago

GlucoTrack Transcript: EGM 2026

Glucotrack to Present at LSI USA '26 Medtech Innovation Summit

Mar 10, 2026, 8:01 AM EDT - 4 months ago

Glucotrack to Present at LSI USA '26 Medtech Innovation Summit

GlucoTrack Proxy statement: Proxy Filing

Feb 9, 2026, 7:00 AM EST - 5 months ago

GlucoTrack Proxy statement: Proxy Filing

GlucoTrack announces USPTO approval for issuance of patents for CBGM platform

2026-01-29T13:10:24.000Z - 6 months ago

GlucoTrack announces USPTO approval for issuance of patents for CBGM platform

Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform

Jan 29, 2026, 8:01 AM EST - 6 months ago

Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform

GlucoTrack Proxy statement: Proxy Filing

Jan 29, 2026, 7:00 AM EST - 6 months ago

GlucoTrack Proxy statement: Proxy Filing

GlucoTrack files to sell 3.22M shares of common stock for holders

2026-01-13T21:10:53.000Z - 6 months ago

GlucoTrack files to sell 3.22M shares of common stock for holders

GlucoTrack Registration statement: Registration Filing

Jan 13, 2026, 7:00 AM EST - 6 months ago

GlucoTrack Registration statement: Registration Filing

GlucoTrack prices 1.03M shares at $3.87 in private placement

2025-12-30T13:05:37.000Z - 7 months ago

GlucoTrack prices 1.03M shares at $3.87 in private placement

Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Dec 30, 2025, 8:00 AM EST - 7 months ago

Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

Nov 13, 2025, 4:05 PM EST - 8 months ago

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

GlucoTrack Earnings release: Q3 2025

Nov 13, 2025, 7:00 AM EST - 8 months ago

GlucoTrack Earnings release: Q3 2025

GlucoTrack Quarterly report: Q3 2025

Nov 13, 2025, 7:00 AM EST - 8 months ago

GlucoTrack Quarterly report: Q3 2025

GlucoTrack Transcript: AGM 2025

Nov 7, 2025, 12:00 PM EST - 9 months ago

GlucoTrack Transcript: AGM 2025

GlucoTrack Proxy statement: Proxy Filing

Nov 7, 2025, 7:00 AM EST - 9 months ago

GlucoTrack Proxy statement: Proxy Filing

Glucotrack, Inc. Encourages Shareholders to Vote

Nov 3, 2025, 4:05 PM EST - 9 months ago

Glucotrack, Inc. Encourages Shareholders to Vote

GlucoTrack Proxy statement: Proxy Filing

Nov 3, 2025, 7:00 AM EST - 9 months ago

GlucoTrack Proxy statement: Proxy Filing

GlucoTrack Proxy statement: Proxy Filing

Oct 31, 2025, 8:00 AM EDT - 9 months ago

GlucoTrack Proxy statement: Proxy Filing

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

Oct 29, 2025, 4:05 PM EDT - 9 months ago

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

GlucoTrack Inc trading resumes

2025-10-29T13:41:17.000Z - 9 months ago

GlucoTrack Inc trading resumes

GlucoTrack Inc trading halted, volatility trading pause

2025-10-29T13:36:24.000Z - 9 months ago

GlucoTrack Inc trading halted, volatility trading pause

GlucoTrack reminds shareholders to vote on equity purchase agreement

2025-10-28T12:21:41.000Z - 9 months ago

GlucoTrack reminds shareholders to vote on equity purchase agreement

Glucotrack, Inc. Reminds Shareholders to Vote

Oct 28, 2025, 8:00 AM EDT - 9 months ago

Glucotrack, Inc. Reminds Shareholders to Vote

GlucoTrack Proxy statement: Proxy Filing

Oct 28, 2025, 8:00 AM EDT - 9 months ago

GlucoTrack Proxy statement: Proxy Filing

GlucoTrack Proxy statement: Proxy Filing

Oct 15, 2025, 8:00 AM EDT - 9 months ago

GlucoTrack Proxy statement: Proxy Filing

GlucoTrack Registration statement: Registration Filing

Oct 8, 2025, 8:00 AM EDT - 10 months ago

GlucoTrack Registration statement: Registration Filing

GlucoTrack Proxy statement: Proxy Filing

Oct 3, 2025, 8:00 AM EDT - 10 months ago

GlucoTrack Proxy statement: Proxy Filing

GlucoTrack files to sell 20.06M shares of common stock for holders

2025-09-29T21:15:08.000Z - 10 months ago

GlucoTrack files to sell 20.06M shares of common stock for holders

GlucoTrack Registration statement: Registration Filing

Sep 29, 2025, 8:00 AM EDT - 10 months ago

GlucoTrack Registration statement: Registration Filing

GlucoTrack Proxy statement: Proxy Filing

Sep 23, 2025, 8:00 AM EDT - 10 months ago

GlucoTrack Proxy statement: Proxy Filing

GlucoTrack Transcript: Q3 Investor Summit Group Virtual Conference 2025

Sep 16, 2025, 1:30 PM EDT - 10 months ago

GlucoTrack Transcript: Q3 Investor Summit Group Virtual Conference 2025

Why GlucoTrack (GCTK) Stock Jumped Over 100% Today and What Comes Next

2025-09-12T13:42:56.000Z - 11 months ago

Why GlucoTrack (GCTK) Stock Jumped Over 100% Today and What Comes Next

Why Is Glucotrack Stock (GCTK) Up 150% Today?

2025-09-12T12:28:44.000Z - 11 months ago

Why Is Glucotrack Stock (GCTK) Up 150% Today?

Glucotrack to Participate in the Q3 Virtual Investor Summit

Sep 11, 2025, 8:00 AM EDT - 11 months ago

Glucotrack to Participate in the Q3 Virtual Investor Summit

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 14, 2025, 4:05 PM EDT - 1 year ago

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

GlucoTrack Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 1 year ago

GlucoTrack Earnings release: Q2 2025

GlucoTrack Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 1 year ago

GlucoTrack Quarterly report: Q2 2025

GlucoTrack appoints David Hirsh as medical director, cardiology

2025-08-06T12:40:37.000Z - 1 year ago

GlucoTrack appoints David Hirsh as medical director, cardiology

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

GlucoTrack to exhibit at ADCES Annual Meeting

2025-07-31T12:35:20.000Z - 1 year ago

GlucoTrack to exhibit at ADCES Annual Meeting

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Jul 31, 2025, 8:30 AM EDT - 1 year ago

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

GlucoTrack announces repurchase of Series A warrants

2025-07-08T12:41:19.000Z - 1 year ago

GlucoTrack announces repurchase of Series A warrants

Glucotrack Announces Repurchase of Series A Warrants

Jul 8, 2025, 8:30 AM EDT - 1 year ago

Glucotrack Announces Repurchase of Series A Warrants

GlucoTrack Stock (GCTK) Stock Rockets 130% on Diabetes Tracking Data

2025-06-26T01:39:00.000Z - 1 year ago

GlucoTrack Stock (GCTK) Stock Rockets 130% on Diabetes Tracking Data

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 25, 2025, 8:30 AM EDT - 1 year ago

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Jun 12, 2025, 9:05 AM EDT - 1 year ago

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 4, 2025, 8:30 AM EDT - 1 year ago

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

May 28, 2025, 8:30 AM EDT - 1 year ago

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

May 20, 2025, 8:30 AM EDT - 1 year ago

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 14, 2025, 5:10 PM EDT - 1 year ago

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

GlucoTrack Quarterly report: Q1 2025

May 14, 2025, 4:00 PM EDT - 1 year ago

GlucoTrack Quarterly report: Q1 2025

GlucoTrack Earnings release: Q1 2025

May 14, 2025, 4:00 PM EDT - 1 year ago

GlucoTrack Earnings release: Q1 2025

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

May 13, 2025, 8:01 AM EDT - 1 year ago

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

GlucoTrack Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

GlucoTrack Proxy statement: Proxy Filing

GlucoTrack Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

GlucoTrack Proxy statement: Proxy Filing

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Apr 16, 2025, 8:00 AM EDT - 1 year ago

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Apr 3, 2025, 8:01 AM EDT - 1 year ago

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

GlucoTrack Annual report: Q4 2024

Mar 31, 2025, 5:00 PM EDT - 1 year ago

GlucoTrack Annual report: Q4 2024

GlucoTrack Earnings release: Q4 2024

Mar 31, 2025, 5:00 PM EDT - 1 year ago

GlucoTrack Earnings release: Q4 2024

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Mar 19, 2025, 8:01 AM EDT - 1 year ago

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Feb 26, 2025, 8:01 AM EST - 1 year ago

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Feb 4, 2025, 12:24 PM EST - 1 year ago

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Feb 4, 2025, 8:01 AM EST - 1 year ago

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Jan 29, 2025, 9:00 AM EST - 1 year ago

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Glucotrack Announces ISO 13485:2016 Certification

Jan 21, 2025, 8:01 AM EST - 1 year ago

Glucotrack Announces ISO 13485:2016 Certification

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Jan 15, 2025, 8:01 AM EST - 1 year ago

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Glucotrack to Present at TechBio Showcase™ 2025

Jan 7, 2025, 4:05 PM EST - 1 year ago

Glucotrack to Present at TechBio Showcase™ 2025

GlucoTrack Proxy statement: Proxy Filing

Dec 6, 2024, 7:00 AM EST - 1 year ago

GlucoTrack Proxy statement: Proxy Filing

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Dec 3, 2024, 8:30 AM EST - 1 year ago

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

GlucoTrack Proxy statement: Proxy Filing

Nov 22, 2024, 7:00 AM EST - 1 year ago

GlucoTrack Proxy statement: Proxy Filing

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

Nov 14, 2024, 4:30 PM EST - 1 year ago

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

GlucoTrack Quarterly report: Q3 2024

Nov 14, 2024, 7:00 AM EST - 1 year ago

GlucoTrack Quarterly report: Q3 2024

GlucoTrack Registration statement: Registration Filing

Nov 8, 2024, 7:00 AM EST - 1 year ago

GlucoTrack Registration statement: Registration Filing

GlucoTrack Registration statement: Registration Filing

Nov 8, 2024, 7:00 AM EST - 1 year ago

GlucoTrack Registration statement: Registration Filing

GlucoTrack Registration statement: Registration Filing

Nov 4, 2024, 7:00 AM EST - 1 year ago

GlucoTrack Registration statement: Registration Filing

GlucoTrack Registration statement: Registration Filing

Oct 24, 2024, 8:00 AM EDT - 1 year ago

GlucoTrack Registration statement: Registration Filing

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

Oct 22, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

Oct 1, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

GlucoTrack Registration statement: Registration Filing

Sep 30, 2024, 8:00 AM EDT - 1 year ago

GlucoTrack Registration statement: Registration Filing

GlucoTrack Registration statement: Registration Filing

Sep 23, 2024, 8:00 AM EDT - 1 year ago

GlucoTrack Registration statement: Registration Filing

GlucoTrack Registration statement: Registration Filing

Sep 16, 2024, 8:00 AM EDT - 2 years ago

GlucoTrack Registration statement: Registration Filing

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Sep 3, 2024, 9:00 AM EDT - 2 years ago

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

GlucoTrack Proxy statement: Proxy Filing

Aug 19, 2024, 8:00 AM EDT - 2 years ago

GlucoTrack Proxy statement: Proxy Filing

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

Aug 15, 2024, 9:00 AM EDT - 2 years ago

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

GlucoTrack Quarterly report: Q2 2024

Aug 13, 2024, 8:00 AM EDT - 2 years ago

GlucoTrack Quarterly report: Q2 2024

GlucoTrack Proxy statement: Proxy Filing

Aug 9, 2024, 8:00 AM EDT - 2 years ago

GlucoTrack Proxy statement: Proxy Filing

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

Aug 5, 2024, 9:00 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Jun 20, 2024, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Ricksal
Ricksal Jul. 21 at 4:47 AM
$GCTK as long as it’s not delisted you will be fine. These penny stocks make monumental moves when they do move.
0 · Reply
Homer_Simpson82
Homer_Simpson82 Jul. 21 at 2:56 AM
$GCTK no
0 · Reply
Zackpedia
Zackpedia Jul. 20 at 7:34 PM
$GCTK Down to .39, you could’ve sold and bought back now if you wanted.
0 · Reply
OG80
OG80 Jul. 20 at 7:06 PM
$GCTK delist. pay me.
0 · Reply
CallMeMyBeer
CallMeMyBeer Jul. 20 at 5:46 PM
$GCTK
0 · Reply
OG80
OG80 Jul. 20 at 5:20 PM
$GCTK not selling 🖕
0 · Reply
dunkcanfish
dunkcanfish Jul. 20 at 5:05 PM
$GCTK garbage
0 · Reply
Stockswingalert
Stockswingalert Jul. 20 at 1:16 PM
$KNDI .70 here 👇👇👇👇 Literally free money if you have noti’s on using the high frequency trader cc $GCTK last week 104% mover 💰💰💰💰 @Stocktwits for the 🎯🎯🎯👇👇👇📈📈📈
0 · Reply
sloeb
sloeb Jul. 20 at 12:54 PM
$GCTK bullish
0 · Reply
Phazzatrades
Phazzatrades Jul. 20 at 10:48 AM
$GCTK
0 · Reply
OG80
OG80 Jul. 20 at 9:42 AM
$GCTK
0 · Reply
anders_taag
anders_taag Jul. 20 at 9:17 AM
$GCTK wtf
0 · Reply
SKM2086
SKM2086 Jul. 20 at 8:43 AM
$GCTK back into the 30's today at this rate unfortunately. Not the start to the week I wanted.
1 · Reply
katorvix
katorvix Jul. 20 at 4:37 AM
$GCTK - The combined organization integrates Lokahi's dual-engine model and Al-driven asset sourcing and advancement platform with GlucoTrack's existing technology infrastructure to create a scalable framework.
0 · Reply
HMIC
HMIC Jul. 19 at 8:06 PM
$GCTK Look for a run this week.
0 · Reply
m2139m
m2139m Jul. 17 at 11:02 PM
$GCTK https://x.com/cs_marketinginc/status/2078241430800126060?s=46&t=Q2G-rCya1_NXZKiLWKbrhw
0 · Reply
AllAboutTheBread
AllAboutTheBread Jul. 17 at 10:34 PM
$GCTK no
0 · Reply
OG80
OG80 Jul. 17 at 10:12 PM
$GCTK rs coming. inevitable. rs it to death.
0 · Reply
Duskfall
Duskfall Jul. 17 at 9:51 PM
$GCTK Noup...
0 · Reply
Luckyizme
Luckyizme Jul. 17 at 9:32 PM
$GCTK Just checked on my phone on the way home, no run yet ah. Looks like the hedgies had to empty out the margin accounts and sell all the ETF shares they don't own for liquidity to stop another run.🤣 The funny part is, someone drew the short straw and had to stay back in the boiler room on a Friday night with no OT pay.
0 · Reply
shuffle13
shuffle13 Jul. 17 at 9:29 PM
$GCTK completely wrong on what i thought-after seeing the terms of financing with White Lion (this is just me-you do as u do)...but i dont think this stock is buyable at any price-$50 mill eloc discounted vwap over 3 years, $1 mill worth of free shares as a fee and just a full pandoras box...the bait (as usual) in their press release "ai methodologies" guaranteed to set off scanners
0 · Reply
SKM2086
SKM2086 Jul. 17 at 9:14 PM
$GCTK short selling should be illegal, along with all the other blatant manipulation these hedge funds and institutions hold power to. It doesn't help humpty trumpty is fiddling his fingers where they don't belong worse than Joseph fritzl. Corruption eruptions are ruining the global markets. Wet wipes, the lot of them.
0 · Reply